H.C. Wainwright Global Investment Conference
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your POLB notes
27 August 2024 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that Jeremy Skillington, PhD, Chief Executive Officer and David Allmond, Chief Business Officer will present virtually at the H.C. Wainwright 26th Annual Global Investment Conference, being held on 9-11 September 2024 in New York and virtually.
The presentation will be available to view on demand from 12pm BST / 7am ET on Monday 9 September 2024.
In addition to the presentation, management will be available at the conference in New York for in-person one-on-one meetings with investors on 9-11 September. To schedule a meeting, investors should contact their H.C. Wainwright representative or contact Poolbeg directly at ir@poolbegpharma.com.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.